ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 93 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 3.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,596 | -15.7% | 4,610 | 0.0% | 0.00% | – |
| Q2 2023 | $4,264 | +42.1% | 4,610 | +49.5% | 0.00% | -100.0% |
| Q3 2022 | $3,000 | +200.0% | 3,084 | +869.8% | 0.00% | – |
| Q2 2022 | $1,000 | – | 318 | +77.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 179 | -94.5% | 0.00% | -100.0% |
| Q4 2021 | $12,000 | -73.3% | 3,275 | -62.2% | 0.00% | -83.3% |
| Q3 2021 | $45,000 | +60.7% | 8,667 | +31.1% | 0.01% | +100.0% |
| Q2 2021 | $28,000 | +211.1% | 6,610 | +310.6% | 0.01% | +200.0% |
| Q1 2021 | $9,000 | 0.0% | 1,610 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,000 | -30.8% | 1,610 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $13,000 | -68.3% | 1,610 | -60.3% | 0.00% | -66.7% |
| Q2 2020 | $41,000 | +1266.7% | 4,058 | +332.6% | 0.01% | +1100.0% |
| Q1 2020 | $3,000 | – | 938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |